Extrafine Beclomethasone/formoterol compared to Fluticasone/salmeterol Combination Therapy in COPD

Overview of attention for article published in BMC Pulmonary Medicine, March 2014

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

policy: 1 policy source

twitter: 2 X users

Citations

dimensions_citation: 40 Dimensions

Readers on

mendeley: 69 Mendeley

Summary Policy documents X Dimensions citations

So far, Dimensions has found 40 publications that cite this research output.

40

The most recent citing publications are shown below. View all 40 publications that cite this research output on Dimensions.

New Perspectives in Pharmacological Therapy for COPD: Phenotype Classification and Corticosteroids with Bronchodilators

Book chapter (February 2023)

Comparative efficacy and safety of glycopyrronium/formoterol fixed-dose combination versus glycopyrronium monotherapy in patients with moderate-to–severe COPD

Article in Lung India (October 2022)

Assessment of extrafine beclomethasone/formoterol for the treatment of chronic obstructive pulmonary disease: A non-interventional study in a Bulgarian population

Article in Pulmonary Pharmacology & Therapeutics (October 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.